NNGH,
mmp-3 inhibitor ii,
MMP Inhibitor Set I,
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,
161314-17-6,
NGH,
N-Isobutyl-N-(4-methoxyphenylsulfonyl)-glycylhydroxamic Acid,
1rmz,
1z3j,
AC1L9LHM,
CGS 27023A Analog 3,
SCHEMBL598146,
CHEMBL311932,
BDBM13080,
CTK8G1958,
NNGH, >=98% (HPLC),
ZINC3818629,
IN1253,
IN1261,
CCG-207858,
DB08271,
J-009812,
N-hydroxy-2-[N-(2-methylpropyl)4-methoxybenzenesulfonamido]acetamide,
AcetaMide, N-hydroxy-2-[[(4-Methoxyphenyl)sulfonyl](2-Methylpropyl)aMino]-,
N-hydroxy-2-[(4-methoxybenzene)(2-methylpropyl)sulfonamido]acetamide,
N-hydroxy-2-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]acetamide,
N-hydroxy-N~2~-[(4-methoxyphenyl)sulfonyl]-N~2~-(2-methylpropyl)glycinamide,
JIRXORZYIXSWOB-UHFFFAOYSA-N,
CID448002,